[
  {
    "qid": "q1",
    "qtype": "pedersen_macrosomia",
    "question": "Using the modified Pedersen hypothesis, explain how maternal hyperglycemia leads to fetal macrosomia.",
    "gold_path": [
      "maternal_hyperglycemia",
      "placental_glucose_transfer",
      "fetal_hyperinsulinemia",
      "fetal_adipogenesis",
      "fetal_macrosomia"
    ],
    "bad_paths": [
      [
        "maternal_hyperglycemia",
        "prematurity_related_problems"
      ],
      [
        "gestational_diabetes",
        "continuous_glucose_monitoring"
      ]
    ]
  },
  {
    "qid": "q2",
    "qtype": "obesity_inflammation_postpartum_risk",
    "question": "How does obesity-driven inflammation contribute to long-term maternal cardiometabolic risk following a GDM pregnancy?",
    "gold_path": [
      "maternal_obesity",
      "chronic_low_grade_inflammation",
      "insulin_resistance",
      "endothelial_dysfunction",
      "postpartum_cardiometabolic_risk"
    ],
    "bad_paths": [
      [
        "continuous_glucose_monitoring",
        "HbA1c_reduction"
      ],
      [
        "maternal_obesity",
        "neonatal_hypoglycemia"
      ]
    ]
  },
  {
    "qid": "q3",
    "qtype": "insulin_resistance_to_diabetes_transition",
    "question": "In what ways does GDM serve as a clinical model for understanding the transition from insulin resistance to overt diabetes?",
    "gold_path": [
      "pregnancy_insulin_resistance",
      "beta_cell_compensation",
      "beta_cell_stress",
      "beta_cell_failure",
      "type2_diabetes"
    ],
    "bad_paths": [
      [
        "gestational_diabetes",
        "nicu_admission"
      ],
      [
        "placental_glucose_transfer",
        "macrosomia"
      ]
    ]
  }
]